LATAMBif Registry: January 2021 Report

The Latin American Registry of Percutaneous Coronary Bifurcations continues to develop at a steady pace. The aim of this prospective multicenter registry is to assess the reality of percutaneous coronary bifurcation to define its needs and establish effective strategies to perfect the daily clinical practice. 

Bellow you will find data from January 2021, which includes all patients enrolled by the different Latin American centers taking part in the register. 

January data

So far, the registry has included 157 patients of mean age 65 (+- 10.86): 85% men, and 15% women.

Among the risk factors, we have found 84,6% had a history of hypertension, 78,2% dyslipidemia, 12,2% were smokers, 17,9% had type 2 diabetes and 2,6% had type 1 diabetes. In addition, 42,9% had prior PCI, 7,1% prior CABG and 26,9% prior MI.

Registro LATAM BIF - Reporte Mensual Enero 2021

Of all included patients, 37,2% presented chromic coronary syndrome, 26,9% unstable angina, 16,7% Non-ST acute myocardial infarction (NSTEMI), 12,2% were asymptomatic (silent ischemia) 7,1 ST elevation MI (STEMI).

As regards clinical indications, 55,1% received elective indication, 35,3% urgent indication and 9,6 emergency indication.

83,2% of vascular access was transradial (proximal), 3,9% transradial (distal) and12,9% femoral.

Registro Latam Bif - Reporte Mensual Enero 2021 - 2

As to the initial strategy, 71% was the provisional stent technique and 29% the two stent technique.

Registro Latam Bif - Reporte Mensual Enero 2021 - 3
monthly-report-january-2021

How to make part of the LATAM Bif Registry?

Write to latambif@gmail.com. You will receive all the information and documentation required for LATAMBif, coordinated by SOLACI Research.

Why take part in LATAM Bif?

  1. The chance to access your own database dedicated to coronary bifurcations, with unified variables for all centers across Latin America. 
  2. Each center will own their data and will be able to analyze outcomes in real time. 
  3. The chance to interact with centers interested in research and publication throughout the region. 
  4. The chance to present at local and international events the outcomes of LATAM Bif Registry.
  5. In case you might need help to develop research projects and/or carry out statistical analysis, you will have the support of SOLACI Research.
  6. SOLACI Research will provide weekly auditing for all data, initial and annual (mandatory followup), for it to be charged correctly. 

Write now to latambif@gmail.com and start participating of LATAM Bif.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

We invite you to submit scientific papers and challenging clinical cases for the SOLACI & SBHCI 2026 Congress, taking place from July 29 to...

Watch again “Ultrasound Pulses + Calcium = Coronary Lithotripsy” | SOLACI Technicians Webinar

The webinar “Ultrasound Pulses + Calcium = Coronary Lithotripsy”, held on March 24, 2026 via the Zoom platform, is now available for viewing on...

SOLACI invites you to the 5th International Conference on Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology (SOLACI) invites the community to the 5th International Conference on Clinical and Interventional Cardiology (Coronary and Structural),...

Panama Sessions 2026 – Young Interventional Cardiologists Contest. Submit Your Case

The call for submissions is now open to participate in the Young Interventional Cardiologists Competition at the Panama 2026 Regional Meeting, which will take...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...